Literature DB >> 22115729

[Two children with cerebral and retinal hemorrhages: do not diagnose shaken baby syndrome too rapidly].

A Botte1, A Mars, B Wibaut, S De Foort-Dhellemmes, M Vinchon, F Leclerc.   

Abstract

We report on 2 cases associating retinal (RH) and cerebral hemorrhages (CH), which first suggested the diagnosis of shaken baby syndrome (SBS). After an etiologic search, the diagnosis was corrected: the first case was a late hemorrhagic disease of the newborn and the second case hemophilia A. RH is a major feature of SBS, although not pathognomonic. There is no specific RH of SBS but they usually affect the posterior retinal pole. Typically, RHs of SBS are present in both eyes, although unilateral RHs do not exclude the diagnosis of SBS. The relationship between RH and CH has been reported in SBS but also in other diseases. Thus, one must search for hemostasis abnormalities, even though the clinical presentation suggests SBS. Ignoring SBS as well as coming to the conclusion of SBS too quickly should be avoided. Diagnostic difficulties may be related to the number of physicians involved and their interpretation of the facts. These 2 cases underline the need for working as a team that includes hematologists able to interpret coagulation parameters.
Copyright © 2011 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22115729     DOI: 10.1016/j.arcped.2011.10.006

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  2 in total

1.  The Swedish Agency for health technology-report about traumatic shaking: much ado about nothing?

Authors:  Robert A C Bilo
Journal:  Forensic Sci Med Pathol       Date:  2018-08-01       Impact factor: 2.007

2.  Traumatic shaking: The role of the triad in medical investigations of suspected traumatic shaking.

Authors:  Göran Elinder; Anders Eriksson; Boubou Hallberg; Niels Lynøe; Pia Maly Sundgren; Måns Rosén; Ingemar Engström; Björn-Erik Erlandsson
Journal:  Acta Paediatr       Date:  2018-09       Impact factor: 2.299

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.